Endovascular treatmenT for Acute Ischemic Stroke in China (DETECT2-China)

enDovascular trEatmenT for acutE isChemic sTroke in China (DETECT2-China): a Prospective, National, Multi-center, Registry Study

This is a prospective real world registry study, aiming to explore the effectiveness and safety of endovascular treatment of acute ischemic stroke in a Chinese population.

Inclusion Criteria:

• Age: ≥ 18;
• Ischemic stroke confirmed by head CT or MRI;
• Patients receiving endovascular treatment;
• First ever stroke or pre-stroke mRS≤2;
• signed informed consent.

Exclusion Criteria:

• Prestroke mRS≥3;
• Other serious illness that would confound the clinical outcome at 90 days;
• Unavailable neuroimaging data;
• Other unsuitable conditions judged by the investigator